Retension Pharmaceuticals. Inc.
Clinical trials sponsored by Retension Pharmaceuticals. Inc., explained in plain language.
-
New pill for high blood pressure shows promise in early trial
Disease control CompletedThis study tested a new drug called SLx-2101 in 26 adults with moderate to severe high blood pressure. Participants took the drug or a placebo for 12 days to see how well it lowered blood pressure and if it was safe. The goal was to find the best dose for future studies.
Phase: PHASE2 • Sponsor: Retension Pharmaceuticals. Inc. • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
New pill shows promise for lowering blood pressure
Disease control CompletedThis study tested a new drug called SLx-2101 in 38 adults with moderate to severe high blood pressure. Participants took either 5 mg or 10 mg of the drug once a day for 14 days. The goal was to see how well it lowered blood pressure and if it was safe.
Phase: PHASE2 • Sponsor: Retension Pharmaceuticals. Inc. • Aim: Disease control
Last updated May 12, 2026 13:42 UTC